期刊
AMERICAN JOURNAL OF MEDICINE
卷 127, 期 6, 页码 479-483出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2014.02.017
关键词
Clostridium difficile infections; Diarrhea; Fecal microbiota transplantation; Gut microbiota
In recent years, Clostridium difficile infections have become more frequent, more severe, more refractory to standard treatment, and more likely to recur. Current antibiotic treatment regimens for Clostridium difficile infection alter the normal gut flora, which provide colonization resistance against Clostridium difficile. Over the past few years, there has been a marked increase in the knowledge of the gut microbiota and its role in health maintenance and disease causation. This has, fortuitously, coincided with the use of a unique microbial replacement therapy, fecal microbiota transplantation, in the treatment of patients with multiple recurrent Clostridium difficile infections. We briefly review current knowledge of the gut microbiota's functions. We then review the indications for use of fecal microbiota transplantation in Clostridium difficile infection, the techniques employed, and results of treatment. Fecal microbiota transplantation has been shown to be efficacious for patients with multiply recurrent Clostridium difficile infections ( reported cure rates of 90%), with an excellent short- term safety profile, and has been included in the American College of Gastroenterology treatment guidelines for this troublesome disease. (C) 2014 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据